Herbal hepatotoxicity: A case of difficult interpretation

European Review for Medical and Pharmacological Sciences

Volumn 14, Issue 10, 2010, Pages 865-870

  Valente, G ^a   Sanges, Marco ^a   Campione, S ^a   Bellevicine, C ^a   De Franchis, G ^a   Sollazzo, R ^a   Mattera, D ^a   Cimino, L ^a   Vecchione, R ^a   D'Arienzo, A ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Chinese herbs hepatotoxicity; Cimicifuga racemosa; Glycyrrhizin; Phytomedicine knowledge; Polygonum multiflorum

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CHINESE DRUG; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN; HERBACEOUS AGENT; LACTATE DEHYDROGENASE; URSODEOXYCHOLIC ACID;

ABDOMINAL PAIN; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE DUCT OBSTRUCTION; BILIRUBIN BLOOD LEVEL; CASE REPORT; CHOLECYSTECTOMY; CHOLESTASIS; DRUG EFFICACY; EOSINOPHILIA; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; JAUNDICE; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER BIOPSY; LIVER CELL DAMAGE; LIVER INJURY; LIVER TOXICITY; PHYTOTHERAPY; TOXIC HEPATITIS;

ADULT; DRUG-INDUCED LIVER INJURY; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; PHYTOTHERAPY; URSODEOXYCHOLIC ACID;

EID: 79951822845     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. DE SMET PAGM. Herbal remedies. N Engl J Med 2002; 347: 2046-2056.
2. STICKEL F, PATSENKER E, SCHUPPAN D. Herbal hepatotoxicity. J Hepatol 2005; 43: 901-910.
3. LARREY D. Hepatotoxicity of herbal remedies. J Hepatol 1997; 26(Suppl 1): 47-51.
4. SCHIANO T. Liver injury from herbs and other botanicals. In: Gitlin N, ed. Clinics in Liver Disease. Chicago: WB Saunders, 1998: pp. 607-630.
5. PAK E, ESRASON KT, WU VH. Hepatotoxicity of herbal remedies: an emerging dilemma. Prog Transplant 2004; 14: 91-96.
6. BARNES J, MILLS SY, ABBOT NC, WILLOUGHBY M, ERNST E. Different standards for reporting ADRs to herbal remedies and conventional OTC medicines face-to-face interviews with 515 users of herbal remedies. Br J Clin Pharmacol 1998; 45: 496-500.
7. VICKERS KA, JOLLY KB, GREENFIELD SM. Herbal medicine: women's views, knowledge and interaction with doctors: a qualitative study. BMJ Complement Altern Med 2006; 6: 40.
8. SAPER RB, KALES SN, PAQUIN J, BURNS MJ, EISENBERG DM, DAVIS RB, PHILLIPS RS. Heavy metal content of ayurvedic herbal medicine products. JAMA 2004; 292: 2868-2873.
9. EL-NAHHAL Y. Contamination and safety status of plant and food in Arab countries. J Appl Sci 2004; 4: 411-417.
10. ERNST E, WEIHMAYR T. UK and German media differ over complementary medicine. Br Med J 2000; 321: 707.
11. BLUMENTHAL M. Market report. Herbalgram 2002; 55: 60.
12. MACLENNAN AH, WILSON DH, TAYLOR AW. The escalating cost and prevalence of alternative medicine. Prev Med 2002; 35: 166-173.
13. MOORE J, PHIPPS K, MARCER D, LEWITH G. Why do people seek treatment by alternative medicine. BMJ 1985; 290: 28-29.
14. HARRISON RA, HOLT D, PATTISON DJ, ELTON PJ. Who and how many people are taking herbal supplements? A survey of 21,923 adults. Int J Vitam Nutr Res 2004; 74: 183-186.
15. ERNST E. The role of complementary and alternative medicine. BMJ 2000; 321: 1133-1135.
16. ERNST E. Herb-drug interactions-an update. Perfusion 2003; 16: 175-194.
17. WATKINS PB, SEEFF LB. Drug-induced liver injury: summary of a single topic clinical research conference. Hepatology 2006; 43: 618-631.
18. ERNST E. Challenges for phytopharmacovigilance. Postgrad Med J 2004; 80: 249-250.
19. LEE WM, SENIOR JR. Recognizing drug-induced liver injury: current problems, possible solutions. Toxicol Pathol 2005; 33: 155-164.
20. DANAN G, BENICHOU C. Causality assessment of adverse reactions to drugs-I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 1993; 46: 1323-1330.
21. LEE WM. Assessing causality in drug-induced liver injury. J Hepatol 2000; 33: 1003-1005.
22. ANDRADE RJ, ROBLES M, FERNÁNDEZ-CASTAÑER A, LÓPEZ-ORTEGA S, LÓPEZ-VEGA MC, LUCENA MI. Assessment of drug-induced hepatotoxicity in clinical practice: a challenge for gastroenterologists. World J Gastroenterol 2007; 13: 329-340.
23. TESCHKE R, SCHWARZENBOECK A, HENNERMANN KH. Causality assessment in hepatotoxicity by drugs and dietary supplements. Br J Clin Pharmacol 2008; 66: 758-766.
24. MARIA VA, VICTORINO RM. Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis. Hepatology 1997; 26: 664-669.
25. AITHAL GP, RAWLINS MD, DAY CP. Clinical diagnostic scale: a useful tool in the evaluation of suspected hepatotoxic adverse drug reactions. J Hepatol 2000; 33: 949-952.
26. BENICHOU C. Criteria of drug-induced liver disorders. Report of an international consensus meeting. J Hepatol 1990; 11: 272-276.
27. TAJIRI K, SHIMIZU Y. Practical guidelines for diagnosis and early management of drug-induced liver injury. World J Gastroenterol 2008; 14: 6774-6785.
28. S. VERMA, N. KAPLOWITZ. Diagnosis, management and prevention of drug-induced liver injury. Gut 2009; 58: 1555-1564.
29. WATKINS PB. Idiosyncratic liver injury: challenges and approaches. Toxicol Pathol 2005; 33: 1-5.
30. KAPLOWITZ N. Idiosyncratic drug hepatotoxicity. Nat Rev Drug Discov 2005; 4: 489-499.
31. BUT PP, TOMLINSON B, LEE KL. Hepatitis related to the Chinese medicine Shou-wu-pian manufactured from Polygonum multiflorum. Vet Hum Toxicol 1996; 38: 280-282.
32. PARK GJ, MANN SP, NGU MC. Acute hepatitis induced by Shou-Wu-Pian, a herbal product derived from Polygonum multiflorum. J Gastroenterol Hepatol 2001; 16: 115-117.
33. MAZZANTI G, BATTINELLI L, DANIELE C, MASTROIANNI CM, LICHTNER M, COLETTA S, COSTANTINI S. New case of acute hepatitis following the consumption of Shou Wu Pian, a Chinese herbal product derived from Polygonum multiflorum. Ann Intern Med 2004; 140: W30.
34. PANIS B, WONG DR, HOOYMANS PM, DE SMET PA, ROSIAS PP. Recurrent toxic hepatitis in a Caucasian girl related to the use of Shou-Wu-Pian, a Chinese herbal preparation. J Pediatr Gastroenterol Nutr 2005; 41: 256-258.
35. CARDENAS A, RESTREPO JC, SIERRA F, CORREA G. Acute hepatitis due to shen-min: a herbal product derived from Polygonum multiflorum. J Clin Gastroenterol 2006; 40: 629-632.
36. WESTENDORF J. Anthranoid derivatives-General discussion. In: De Smet PAGM, Keller K, Hansel, Chandler R, eds. Adverse Effects of Herbal Drugs. Berlin: Springer-Verlag, 1993; 2: 105-118.
37. WHITING PW, CLOUSTON A, KERLIN P. Black cohosh and other herbal remedies associated with acute hepatitis. Med J Aust 2002; 177: 432-435.
38. LONTOS S, JONES RM, ANGUS PW, GOW PJ. Acute liver failure associated with the use of herbal preparations containing black cohosh. Med J Aust 2003; 179: 390-391.
39. O'CONNOR AM, MEREL N, TE HS, COHEN SM. A case of autoimmune hepatitis associated with the use of black cohosh. Am J Gastroenterol 2003; 98(Suppl): 5165.
40. COHEN SM, O'CONNOR AM, HART J, MEREL N, TE HS. Autoimmune hepatitis associated with the use of black cohosh. Menopause 2004; 11: 575-577.
41. LEVITSKY J, ALLI TA, WISECARVER J, SORRELL MF. Fulminant liver failure associated with the use of black cohosh. Dig Dis Sci 2005; 50: 538-539.
42. LYNCH CR, FOLKERS ME, HUTSON WR. Fulminant hepatic failure associated with the use of black cohosh: a case report. Liver Transpl 2006; 12: 989-992.
43. VANNACCI A, LAPI F, GALLO E, VIETRI M, TOTI M, MENNITI-IPPOLITO F, RASCHETTI R, FIRENZUOLI F, MUGELLI A. A case of hepatitis associated with long term use of Cimicifuga racemosa. Del Med J 2007; 79: 441-444.
44. NISBET BC, O'CONNOR RE. Black cohosh-induced hepatitis. Del Med J 2008; 80: 223-224.
45. CHOW EC, TEO M, RING JA, CHEN JW. Liver failure associated with the use of black cohosh for menopausal symptoms. Med J Aust 2008; 188: 420-422.
46. MAHADY GB, LOW DOG T, BARRETT ML, CHAVEZ ML, GARDINER P, KO R, MARLES RJ, PELLICORE LS, GIANCASPRO GI, SARMA DN. United States Pharmacopeia review of the black cohosh case reports of hepatotoxicity. Menopause 2008; 15: 628-638.
47. CHITTURI S, FARELL GC. Hepatotoxic slimming aids and other herbal hepatotoxins. J Gastroenterol Hepatol 2008; 23: 366-373.
48. ISHII M, MIYAZAKI Y, YAMAMOTO T, MIURA M, UENO Y, TAKAHASHI T, TOYOTO T. A case of drug-induced ductopenia resulting in fatal biliary cirrhosis. Liver 1993; 13: 227-231.
49. PITTLER MH, ERNST E. Systematic review: hepatotoxic events associated with herbal medicinal products. Aliment Pharmacol Ther 2003; 18: 451-471.
50. LI B, WANG Z, FANG JJ, XU CY, CHEN WX. Evaluation of prognostic markers in severe drug-induced liver disease. World J Gastroenterol 2007; 13: 628-632.
51. HULLAR TE, SAPERS BL, RIDKER PM, JENKINS RL, HUTH TS, FARRAYE FA. Herbal toxicity and fatal hepatic failure. Am J Med 1999; 106: 267-268.
52. CHENG B, HUNG CT, CHIU W. Herbal medicine and anaesthesia. Hong Kong Med J 2002; 8: 123-130.
53. CHITTURI S, FARRELL GC. Herbal hepatotoxicity: An expanding but poorly defined problem. J Gastroenterol Hepatol 2000; 15: 1093-1099.
54. ERNST E. Risks associated with complementary therapies. In: Dukes, MNG, Aronson, JK, eds. Meyler's Side Effects of Drugs, 14th edn. Amsterdam: Elsevier 2000; pp. 1649-1681.